{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:41:51Z","timestamp":1788918111849,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460613"],"award-info":[{"award-number":["82460613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20232BAB206177"],"award-info":[{"award-number":["20232BAB206177"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20242BAB20467"],"award-info":[{"award-number":["20242BAB20467"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016086","name":"Key Laboratory in Science and Technology Development Project of Suzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.mtbio.2026.102767","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:26:02Z","timestamp":1767659162000},"page":"102767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Ginsenoside Rh2- functionalized liposomes enhanced BRD4-PROTAC delivery and antitumor efficacy via improved tumor targeting and ECM remodeling"],"prefix":"10.1016","volume":"36","author":[{"given":"Lijuan","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenpeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caisheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9448-4401","authenticated-orcid":false,"given":"Weiliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.mtbio.2026.102767_bib1","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1039\/D2CS00220E","article-title":"Chemistries of bifunctional protac degraders","volume":"51","author":"Cao","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"10","key":"10.1016\/j.mtbio.2026.102767_bib2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.mtbio.2026.102767_bib3","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"Protacs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2026.102767_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116166","article-title":"Annual review of protac degraders as anticancer agents in 2022","volume":"267","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.mtbio.2026.102767_bib5","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1039\/D2CS00478J","article-title":"Protac degraders as chemical probes for studying target biology and target validation","volume":"51","author":"Nemec","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.mtbio.2026.102767_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"Protac targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.mtbio.2026.102767_bib7","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of protac degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"19","key":"10.1016\/j.mtbio.2026.102767_bib8","doi-asserted-by":"crossref","first-page":"9582","DOI":"10.1039\/D4CS00411F","article-title":"Proteolysis-targeting drug delivery system (prodds): integrating targeted protein degradation concepts into formulation design","volume":"53","author":"Chen","year":"2024","journal-title":"Chem. Soc. Rev."},{"issue":"13","key":"10.1016\/j.mtbio.2026.102767_bib9","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (protac) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"42","key":"10.1016\/j.mtbio.2026.102767_bib10","doi-asserted-by":"crossref","first-page":"28502","DOI":"10.1021\/acsnano.4c09800","article-title":"Advancing proteolysis targeting chimera (PROTAC) nanotechnology in protein homeostasis reprograming for disease treatment","volume":"18","author":"Wu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.102767_bib11","article-title":"Nanoparticle-mediated targeted protein degradation: an emerging therapeutics technology","author":"Baker","year":"2025","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"Pt A","key":"10.1016\/j.mtbio.2026.102767_bib12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jcis.2024.08.185","article-title":"Co-delivery of protac and sirna via novel liposomes for the treatment of malignant tumors","volume":"678","author":"Zhang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2026.102767_bib13","article-title":"Liposomal stat3-degrading protac prodrugs promote anti-hepatocellular carcinoma immunity via chemically reprogramming cancer stem cells","author":"Wang","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.102767_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.102767_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124973","article-title":"Liposomes-mediated enhanced antitumor effect of docetaxel with brd4-protac as synergist for breast cancer chemotherapy\/immunotherapy","volume":"668","author":"Chen","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102767_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41420-023-01775-6","article-title":"Super-enhancers and the super-enhancer reader brd4: tumorigenic factors and therapeutic targets","volume":"9","author":"Qian","year":"2023","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102767_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102767_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12964-023-01319-6","article-title":"BRD4\/nuclear PD-L1\/RelB circuit is involved in the stemness of breast cancer cells","volume":"21","author":"Kim","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"12","key":"10.1016\/j.mtbio.2026.102767_bib19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41419-022-05505-1","article-title":"Regulation of programmed cell death by brd4","volume":"13","author":"Hu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.mtbio.2026.102767_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrm.2016.143","article-title":"Functions of bromodomain-containing proteins and their roles in homeostasis and cancer","volume":"18","author":"Fujisawa","year":"2017","journal-title":"Nat. Rev. Mol. Cell Bio."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102767_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40820-020-00472-8","article-title":"One stone four birds: a novel liposomal delivery system multi-functionalized with ginsenoside rh2 for tumor targeting therapy","volume":"12","author":"Hong","year":"2020","journal-title":"Nano-Micro Lett."},{"issue":"2","key":"10.1016\/j.mtbio.2026.102767_bib22","first-page":"219","article-title":"Effect of the structure of ginsenosides on the in vivo fate of their liposomes","volume":"17","author":"Chen","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.mtbio.2026.102767_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112627","article-title":"Anticancer property of ginsenoside rh2 from ginseng","volume":"203","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.mtbio.2026.102767_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jgr.2022.09.011","article-title":"The ways for ginsenoside rh2 to fight against cancer: the molecular evidences in vitro and in vivo","volume":"47","author":"Hu","year":"2023","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.mtbio.2026.102767_bib25","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.2147\/IJN.S437733","article-title":"Ginsenoside rh2-based multifunctional liposomes for advanced breast cancer therapy","volume":"19","author":"Hong","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"15","key":"10.1016\/j.mtbio.2026.102767_bib26","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.7150\/thno.34953","article-title":"Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer","volume":"9","author":"Hong","year":"2019","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.mtbio.2026.102767_bib27","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.apsb.2022.02.009","article-title":"A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and m2 macrophages polarization","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.102767_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2022.12.035","article-title":"BRD4 proteolysis-targeting chimera nanoparticles sensitized colorectal cancer chemotherapy","volume":"354","author":"He","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.102767_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2024.06.062","article-title":"Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7\/8 agonist enhances cancer immunotherapy","volume":"372","author":"Dang","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.102767_bib30","article-title":"Enhanced anti-glioma efficacy of doxorubicin with brd4 protac degrader using targeted nanoparticles","volume":"16","author":"He","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2026.102767_bib31","first-page":"255","article-title":"Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy","volume":"43","author":"Lu","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2026.102767_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.actbio.2018.09.040","article-title":"Programmed ph\/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo","volume":"81","author":"Chen","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2026.102767_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113814","article-title":"Metal phenolic networks-driven bufalin homodimeric prodrug nano-coassemblies for ferroptosis-augmented tumor therapy","volume":"383","author":"Wu","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.102767_bib34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jconrel.2024.01.055","article-title":"SiATG5 -loaded cancer cell membrane-fused liposomes induced increased uptake of albumin-bound chemotherapeutics by pancreatic cancer cells","volume":"367","author":"Yan","year":"2024","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.mtbio.2026.102767_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj1262","article-title":"Versatile ginsenoside rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches","volume":"8","author":"Xia","year":"2022","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.mtbio.2026.102767_bib36","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.apsb.2022.01.005","article-title":"Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.102767_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114503","article-title":"Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: towards bypassing EPR","volume":"189","author":"Amin","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.102767_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-loaded ginsenoside rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.mtbio.2026.102767_bib39","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.apsb.2022.07.011","article-title":"Doxorubicin-conjugated sirna lipid nanoparticles for combination cancer therapy","volume":"13","author":"Butowska","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.mtbio.2026.102767_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.102767_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122056","article-title":"Tumor-specific activated nano-domino-crispr to amplify intrinsic oxidative and activate endogenous apoptosis for spatiotemporally specific therapy","volume":"295","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.102767_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113656","article-title":"Unsaturated fatty acid-doped liposomes deliver piperine to deactivate defensive mechanism for ferroptosis in cancer therapy","volume":"382","author":"Wong","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.102767_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.102767_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2023.10.023","article-title":"Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance","volume":"364","author":"Xia","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.102767_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113632","article-title":"Acetyl-lysine human serum albumin nanoparticles activate cd44 receptors, with preferential uptake by cancer stem cells, leading to tumor eradication","volume":"382","author":"Xiong","year":"2025","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102767_bib46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12951-022-01623-2","article-title":"Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes","volume":"20","author":"Xia","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.102767_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113912","article-title":"Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation","volume":"156","author":"Xiaodan","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"15","key":"10.1016\/j.mtbio.2026.102767_bib48","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1021\/acs.nanolett.5c00298","article-title":"A nano-strategy for advanced triple-negative breast cancer therapy by regulating intratumoral microbiota","volume":"25","author":"Gao","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.102767_bib49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jconrel.2024.01.009","article-title":"Replacing cholesterol with asiatic acid to prolong circulation and enhance anti-metastatic effects of non-pegylated liposomes","volume":"366","author":"Zhang","year":"2024","journal-title":"J. Contr. Release"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:25:05Z","timestamp":1773966305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S2590006426000098"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102767","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rh2- functionalized liposomes enhanced BRD4-PROTAC delivery and antitumor efficacy via improved tumor targeting and ECM remodeling","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102767"}}